Prolonged asystole during head-up tilt table testing after beta blockade

Area of Science:

• Cardiology
• Neurology

Background:

• Neurally mediated vasodepressor syncope is a common condition with a generally benign prognosis.
• A less common, malignant form of syncope has been identified.
• Head-up tilt table testing aids in diagnosing syncope and guiding therapy selection.

Observation:

• Beta blockade is a common therapeutic approach for neurally mediated vasodepressor syncope.
• A case report details a patient experiencing asystole during head-up tilt table testing.
• This event occurred after the patient received beta blocker treatment.

Findings:

• The case highlights a potentially severe adverse reaction to beta blockers in a specific syncope subtype.
• Asystole during tilt table testing suggests a significant cardiovascular response to the medication.

Implications:

• This finding necessitates careful consideration of beta blocker therapy in patients with malignant neurally mediated vasodepressor syncope.
• Further research may be warranted to explore the safety and efficacy of beta blockers in different forms of syncope.
• Clinical practice guidelines may need to be updated to reflect this potential risk.